Pyridoxine therapy in a patient with severe hydrazine sulfate toxicity.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10890675.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To report hydrazine sulfate as a cause of severe encephalopathy and to report its response to high-dose pyridoxine therapy. Case report. An adult six-bed medical/surgical intensive care unit of a general hospital. One patient who developed severe encephalopathy after hydrazine sulfate. 5 g i.v. pyridoxine. After 180 mg/day for 2 wks followed by 360 mg/day of hydrazine sulfate ingestion, our patient suffered severe encephalopathy. He received mechanical ventilation with attendant supportive measures and high-dose pyridoxine. The patient's encephalopathy resolved 24 hrs after receiving pyridoxine. Severe encephalopathy could result from hydrazine sulfate toxicity. High-dose pyridoxine is an effective treatment to reverse this encephalopathy.
Medical subject headings
- Antineoplastic Agents
- Brain Diseases
- Hydrazines
- Pyridoxine